# A Study of Hemay005 in Adult With Atopic Dermatitis

> **NCT05769946** · PHASE2 · COMPLETED · sponsor: **Ganzhou Hemay Pharmaceutical Co., Ltd** · enrollment: 79 (actual)

## Conditions studied

- Hemay005, Atopic Dermatitis

## Interventions

- **DRUG:** Hemay005

## Key facts

- **NCT ID:** NCT05769946
- **Lead sponsor:** Ganzhou Hemay Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-24
- **Primary completion:** 2024-01-24
- **Final completion:** 2024-02-21
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05769946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05769946, "A Study of Hemay005 in Adult With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05769946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*